Učitavanje...
The metabolic regulator ERRα, a downstream target of HER2/IGF-1, as a therapeutic target in breast cancer
A genomic signature designed to assess the activity of the estrogen-related receptor alpha (ERRα) was used to profile more than eight hundred breast tumors, revealing a shorter disease-free survival in patients with tumors exhibiting elevated receptor activity. Importantly, this signature also predi...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3199323/ https://ncbi.nlm.nih.gov/pubmed/22014575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2011.08.023 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|